TECHNOLOGY LICENSING OPPORTUNITY: Multi-Channel Atomic Magnetometer (MCAM)
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
TRIAD - DOE CONTRACTOR
Contract Value
Not provided
Codes & Classification
Solicitation Number
S-133667
NAICS
334516 - Analytical Laboratory Instrument Manufacturing
Classification Code
6635
Additional Details
The Department of Energy, through its contractor TRIAD at Los Alamos National Laboratory (LANL), is announcing a technology licensing opportunity for the patented Multi-Channel Atomic Magnetometer (MCAM). This special notice, classified under NAICS code 334516 (Analytical Laboratory Instrument Manufacturing) and Product Service Code 6635, invites interested parties to explore licensing arrangements for this innovative quantum sensing technology. The opportunity is not a solicitation for external development services, but rather an invitation to commercialize and integrate the MCAM into market-ready solutions.
The MCAM represents a significant advancement in biomagnetic sensing technology. Unlike traditional multichannel atomic magnetometers that require separate vapor cells and optical systems for each sensing channel, the MCAM utilizes a single, shared vapor cell and optical system to generate multiple independent sensing channels simultaneously. This architecture enables the capture of ultra-faint biomagnetic signals from sources such as the brain and heart, achieving sensitivity levels comparable to cryogenic SQUID-based systems but at approximately one-tenth the per-channel cost and without the need for liquid helium.
The core of the MCAM is a large alkali-metal vapor cell paired with broad pump and probe laser beams, read out by a photodiode array. This configuration provides 16 independent sensing channels within a single module, which can be scaled into helmet-style arrays comprising hundreds of channels. The design is inherently flexible, allowing the sensor array to conform to the patient’s anatomy rather than requiring the patient to fit into a fixed cryogenic dewar. This flexibility accelerates magnetic imaging workflows and broadens the range of potential applications.
Key technical features include operation in the spin-exchange relaxation-free (SERF) regime, which aligns atomic spins within the vapor cell using optical pumping. The system detects magnetic fields by measuring the rotation of the probe beam’s polarization, induced by the Faraday effect, with each photodiode pixel corresponding to a localized sensing volume. The use of buffer gas restricts atomic motion, ensuring that each pixel functions as an independent channel. Additional design elements, such as a rear mirror for beam folding and integrated Pyrex wire heaters, optimize sensitivity and operational stability.
The MCAM’s patented shared-cell architecture offers several advantages:
- A clear development path toward micrometer-scale spatial resolution, enabling cellular-scale magnetic imaging.
- Sensitivity in the low tens of femtotesla per root hertz, rivaling cryogenic SQUID arrays while operating at room temperature.
- Significant cost reduction by sharing critical components across multiple channels.
- Elimination of liquid cryogen requirements, reducing operational complexity and costs.
- Modular, fiber-coupled sensor heads that can be repositioned and scaled for various configurations, including pediatric and adaptive neuroimaging.
- Enhanced spatial resolution through minimized sensor-to-source distance.
Market applications for the MCAM are extensive and include medical diagnostic imaging (such as magnetoencephalography and magnetocardiography), pediatric and adaptive neuroimaging, micro-scale biomagnetic imaging, cancer diagnostics via magnetic nanoparticle imaging, low-field and portable MRI, geomagnetic surveying, and advanced instrumentation for fundamental physics and biomagnetism research.
The technology is currently at Technology Readiness Level (TRL) 4 and is protected under U.S. Patent No. 11,105,865. LANL’s licensing program offers both exclusive and non-exclusive agreements, aiming to transition laboratory-developed inventions into commercial innovations. Interested parties are encouraged to contact the LANL Technology Partnerships Office for further discussion and to explore how the MCAM can enhance their product offerings.
The place of performance is Los Alamos, New Mexico, and there are no set-aside requirements associated with this opportunity. The primary and secondary contacts for this notice are Kathleen McDonald and Lindsay Augustyn, both reachable at [email protected]. Additional information about the technology and the licensing process can be found at the provided LANL web resources.
This notice remains active, with a response deadline of December 13, 2026. Contractors and companies with expertise in analytical instrumentation, quantum sensing, or medical imaging technologies are encouraged to evaluate this opportunity for alignment with their strategic objectives and capabilities.
For full details and to initiate discussions, please refer to the official notice at: https://sam.gov/opp/e0bbb6607f5441fd992ef4acd46977f2/view.